CIG Q1 2026 Earnings EPS Beat Fails to Ignite Stock as Revenue Details Remain Absent ZBIO Q1 2026 Earnings Narrower Loss Surprises Analysts as Pipeline Progress Continues ATLCL Q1 2026 Earnings Strong EPS Beat Drives Modest Stock Gain NuCana Q3 2024 Earnings SmallerthanExpected Loss as Biotech Advances Oncology Pipeline SION Q1 2026 Earnings ClinicalStage Biotech Misses Estimates with Wider Net Loss United Security Bancshares UBFO Q4 2025 Earnings EPS of 019 Reported Stock Unchanged